Menu
  • Request Samples
  • RESOURCES
  • Important Safety Information
  • Product Monograph
  • EN
  • FR
Menu
  • MECHANISM OF ACTION
  • DOSING & ADMINISTRATION
  • EFFICACY RESULTS
  • SAFETY PROFILE
  • SUMMARY & REFERENCES

Clinical use:

  • The safety and efficacy of BEPREVE® have not been established in pediatric patients under 3 years of age
  • Efficacy of BEPREVE® in pediatric patients with age < 10 was extrapolated from clinical trials conducted in pediatric patients with age >10 and in adults

Relevant warnings and precautions:

  • For topical ophthalmic use only
  • Do not touch the eyelids or surrounding areas with the dropper tip of the bottle and keep bottle tightly closed when not in use
  • Do not use to treat contact lens-related irritation
  • Do not instill while wearing contact lenses. Lenses may be reinserted after 10 minutes following administration.
  • Should not be used in pregnant women unless the benefit to the mother justifies the potential risk to the fetus
  • Caution when administered to nursing women

For more information:

Please consult the Product Monograph at
https://pro.bausch.ca/wp-content/uploads/2019/11/bepreve-pm-en.pdf for important information relating to adverse reactions, drug interactions, and dosing information that has not been discussed in this piece. The Product Monograph is also available by calling 1-800-361-4261.

Please Enter the Following
Information to Access the Site

Enter Your License Number
  • Contact us
  • Legal Notice & Privacy Policy
Bausch Lomb

Bausch + Lomb Corporation
® is a trademark of Bausch & Lomb Incorporated or its affiliates.
© Bausch + Lomb Corporation
BEP.0003.CA.24-EN

PAAB Logo
check mark

Your request has been sent.